1. Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2‐negative breast cancer. Issue 17 (13th June 2014) Authors: Kaufman, Peter A.; Bloom, Kenneth J.; Burris, Howard; Gralow, Julie R.; Mayer, Musa; Pegram, Mark; Rugo, Hope S.; Swain, Sandra M.; Yardley, Denise A.; Chau, Miu; Lalla, Deepa; Yoo, Bongin; Brammer, Melissa G.; Vogel, Charles L. Journal: Cancer Issue: Volume 120:Issue 17(2014) Page Start: 2657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2‐negative breast cancer. Issue 17 (13th June 2014) Authors: Kaufman, Peter A.; Bloom, Kenneth J.; Burris, Howard; Gralow, Julie R.; Mayer, Musa; Pegram, Mark; Rugo, Hope S.; Swain, Sandra M.; Yardley, Denise A.; Chau, Miu; Lalla, Deepa; Yoo, Bongin; Brammer, Melissa G.; Vogel, Charles L. Journal: Cancer Issue: Volume 120:Issue 17(2014) Page Start: 2657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer. Issue 9 (20th March 2023) Authors: Vogel, Charles L.; Cobleigh, Melody A.; Tripathy, Debu; Gutheil, John C.; Harris, Lyndsay N.; Fehrenbacher, Louis; Slamon, Dennis J.; Murphy, Maureen; Novotny, William F.; Burchmore, Michael; Shak, Steven; Stewart, Stanford J.; Press, Michael Journal: Journal of clinical oncology Issue: Volume 41:Issue 9(2023) Page Start: 1638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunological Studies in Ugandan Patients with Hepatocellular Carcinoma. Issue 5844 (6th January 1973) Authors: Primack, Aron; Vogel, Charles L.; Barker, Lewellys F. Journal: BMJ Issue: Volume 1:Issue 5844(1973) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease. Issue 8 (10th March 2023) Authors: Cobleigh, Melody A.; Vogel, Charles L.; Tripathy, Debu; Robert, Nicholas J.; Scholl, Susy; Fehrenbacher, Louis; Wolter, Janet M.; Paton, Virginia; Shak, Steven; Lieberman, Gracie; Slamon, Dennis J. Journal: Journal of clinical oncology Issue: Volume 41:Issue 8(2023) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗